Swarajya

Our View
MagazineHeadlinesVideosBooksस्वराज्यEconomyCultureEvents
User Profile
Subscribe
Swarajya
Subscribe
  • Our View
  • Headlines
  • Magazine
Swarajya
  • Politics
  • Economics
  • Business
  • Culture
  • Books & Ideas
  • World
  • Defence
  • Energy & Infrastructure
  • Science
  • Technology
  • Heritage
  • Videos
  • Archives
  • Blogs
  • News Brief
  • Subscriber login
  • Politics
  • Economics
  • Business
  • Culture
  • Books & Ideas
  • World
  • Defence
  • Energy & Infrastructure
  • Science
  • Technology
  • Heritage
  • Videos
  • Archives
  • Blogs
  • News Brief

ICMR

Mixed Dose Of Covaxin, Covishield Generates Four Times More Antibodies, Says Study
Mixed Dose Of Covaxin, Covishield Generates Four Times More Antibodies, Says StudyPTIJan 4, 2022 11:51 AM +05:30 IST
Omicron Covid Variant: Two Omicron Covid Cases Detected In India, Both In Karnataka
Omicron Covid Variant: Two Omicron Covid Cases Detected In India, Both In KarnatakaSwarajya StaffDec 2, 2021 05:05 PM +05:30 IST
PM Modi Chairs Key Meeting On COVID-19 Situation, Directs Officials To Be Proactive Amid New COVID Strain 'Omicron'
PM Modi Chairs Key Meeting On COVID-19 Situation, Directs Officials To Be Proactive Amid New COVID Strain 'Omicron'Swarajya StaffNov 27, 2021 03:11 PM +05:30 IST
UK Adds Bharat Biotech's Covaxin To Its List Of Approved COVID-19 Vaccines For International Travellers
UK Adds Bharat Biotech's Covaxin To Its List Of Approved COVID-19 Vaccines For International TravellersSwarajya StaffNov 23, 2021 10:53 AM +05:30 IST
How August Turned Out To Be A Major Inflection Point For India’s Vaccination Effort
How August Turned Out To Be A Major Inflection Point For India’s Vaccination EffortSuraj SSep 1, 2021 05:23 PM +05:30 IST
Single-Dose Of Covaxin On Covid-Recovered People Gives Similar Response As Two Doses On Uninfected: ICMR Study
Single-Dose Of Covaxin On Covid-Recovered People Gives Similar Response As Two Doses On Uninfected: ICMR StudySwarajya StaffAug 29, 2021 03:09 PM +05:30 IST
India's Export Of Surplus COVID-19 Testing Kits Projected To Touch 62 Crore Units By September 2021: ICMR
India's Export Of Surplus COVID-19 Testing Kits Projected To Touch 62 Crore Units By September 2021: ICMRSwarajya StaffAug 18, 2021 10:04 AM +05:30 IST
ICMR Survey Reveal Healthcare Workers In Bihar's Buxar Have 94.1 Per Cent Seropositivity
ICMR Survey Reveal Healthcare Workers In Bihar's Buxar Have 94.1 Per Cent SeropositivityBhaswati Guha Majumder Jul 27, 2021 03:30 PM +05:30 IST
Over 60 Per Cent Indians Have Covid-19 Antibodies But 40 Crore Are Still Vulnerable: ICMR
Over 60 Per Cent Indians Have Covid-19 Antibodies But 40 Crore Are Still Vulnerable: ICMR Bhaswati Guha Majumder Jul 21, 2021 02:11 PM +05:30 IST
Covid-19 Third Wave May Hit In August But Would Be Less Severe, Predicts ICMR Expert
Covid-19 Third Wave May Hit In August But Would Be Less Severe, Predicts ICMR Expert Bhaswati Guha Majumder Jul 16, 2021 05:34 PM +05:30 IST
Covaxin Has 93.4 Per Cent Efficacy Against Severe COVID-19 Cases, Overall Efficacy At 77.8 Per Cent: Bharat Biotech
Covaxin Has 93.4 Per Cent Efficacy Against Severe COVID-19 Cases, Overall Efficacy At 77.8 Per Cent: Bharat BiotechSwarajya StaffJul 3, 2021 08:34 AM +05:30 IST
ICMR Tells GoM That Second Wave Of Covid-19 Is Not Yet Over
ICMR Tells GoM That Second Wave Of Covid-19 Is Not Yet OverBhaswati Guha Majumder Jun 29, 2021 05:56 PM +05:30 IST
Potential Covid-19 Third Wave Unlikely To Be As Severe As Second Wave: ICMR-Imperial College Study
Potential Covid-19 Third Wave Unlikely To Be As Severe As Second Wave: ICMR-Imperial College StudySwarajya StaffJun 26, 2021 12:45 PM +05:30 IST
Covaxin And Covishield Works Against Alpha, Beta, Gamma And Delta Variants Of Covid-19: ICMR
Covaxin And Covishield Works Against Alpha, Beta, Gamma And Delta Variants Of Covid-19: ICMRSwarajya StaffJun 26, 2021 11:14 AM +05:30 IST
No, Covaxin Does Not Contain Cow: Here's The Truth
No, Covaxin Does Not Contain Cow: Here's The TruthSwarajya StaffJun 16, 2021 05:37 PM +05:30 IST
'Supply Of Covaxin At Rs 150 Per Dose Not Sustainable': Bharat Biotech Defends Higher Price Of Its Jab For Private Markets
'Supply Of Covaxin At Rs 150 Per Dose Not Sustainable': Bharat Biotech Defends Higher Price Of Its Jab For Private MarketsSwarajya StaffJun 15, 2021 04:06 PM +05:30 IST
ICMR To Conduct National Level Serosurveys To Assess Spread Of COVID-19
ICMR To Conduct National Level Serosurveys To Assess Spread Of COVID-19Swarajya StaffJun 12, 2021 11:41 AM +05:30 IST
Meril Receives ICMR Approval For Covid-19 Self-Test Kit CoviFind, Priced At Rs 250
Meril Receives ICMR Approval For Covid-19 Self-Test Kit CoviFind, Priced At Rs 250Bhaswati Guha Majumder Jun 11, 2021 04:49 PM +05:30 IST
ICMR Approves Two Home-Based Rapid Antigen Test Kits For COVID-19 Testing
ICMR Approves Two Home-Based Rapid Antigen Test Kits For COVID-19 TestingIANSJun 4, 2021 08:13 AM +05:30 IST
Reliance Submits Proposal For Use Of Niclosamide As Potential COVID-19 Drug
Reliance Submits Proposal For Use Of Niclosamide As Potential COVID-19 DrugIANSJun 3, 2021 09:19 AM +05:30 IST
Load More

About Swarajya

Swarajya - a big tent for liberal right of centre discourse that reaches out, engages and caters to the new India.

editor@swarajyamag.com

Useful Links

  • About Us
  • Subscriptions Support
  • Editorial Philosophy
  • Press Kit
  • Fact Check
  • Gift Swarajya
  • Privacy Policy
  • Terms of Use
  • Code of Conduct
  • Plagiarism Policy
  • Refund & Cancellation Policy

Participate

  • Contact Us
  • Write for us
  • Style Guide
  • Advertise
  • Jobs

Stay Connected

  • Artboard 2 Copy 6Created with Sketch.Artboard 2 Copy 10Created with Sketch.Artboard 2 Copy 7Created with Sketch.Artboard 2 Copy 9Created with Sketch.
Copyright: Swarajya. All Rights Reserved.
Powered by Quintype